SESSION ONE: OPAT - WHERE ARE WE NOW?

The video consists of the following presentations:

Welcome & introduction

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

BSAC OPAT Strategy & Key achievements in 2021/22

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Setting the standard for OPAT in Scotland

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

NHS England – taking a strategic approach to OPAT

Conor Jamieson, Regional Antimicrobial Stewardship Lead Midlands Region, NHS England

OPAT developments in Paediatrics

Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital

Panel discussion: How can we share successes to work better together?

All speakers

SESSION TWO: INNOVATIONS IN OPAT/ COPAT DRUG DELIVERY

The video consists of the following presentations:

Aciclovir in elastomerics - It is now possible?

Fekade Sime, NHMRC Emerging Leadership Fellow, University of Queensland Centre for Clinical Research

Probenecid and beta lactams in OPAT/CoPAT - New Zealand experience

Richard Everts, Infectious Diseases Specialist, Nelson Bays Primary Health, New Zealand

One size does not fit all in COPAT - practical considerations

Lee Stewart, Antimicrobials Pharmacist, South Glasgow Hospitals

OPAT vs COPAT outcomes

Peter McKee, Antimicrobial Pharmacist, Southern Health and Social Care Trust, Craigavon Area Hospital

Q&A

SESSION FOUR: CLINICAL CASE STUDIES - INVITED PAPERS FROM OPAT REGIONAL WORKSHOPS & ABSTRACTS

The video consists of the following presentations:

Life prolongation at what cost…..An OPAT story

Carolyn Hemsley, Infectious Diseases and Microbiology Consultant, Guy’s & St Thomas’ NHS Foundation

OPAT and the vulnerable adult

Meghan Perry, Consultant Physician and Honorary Senior Clinical Lecturer in Infectious Diseases and General Internal Medicine, Western General Hospital, Edinburgh

Use of Charlson Comorbidity Index to Predict Risk of Readmission for OPAT Patients: A Quality Improvement Project

Ryan Stubbs, Medical Student, University of Manchester

Q&A

SESSION SIX: INTERNATIONAL OPAT

The video consists of the following presentations:

Overview of OPAT within Europe

Caroline Emilie, Université de Lorraine, France

Overview of OPAT within USA

Monica Mahoney, Clinical Pharmacy Specialist, Infectious Diseases Outpatient ID/OPAT Clinics, Beth Israel Deaconess Medical Center, Boston, USA

Q&A

Closing remarks

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Welcome & introduction

David Jenkins, Lead Infection Prevention Clinician, University Hospital Leicester & BSAC Vice-President

OPAT - What did NORS tell us?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases & Stewardship, OPAT service lead at Imperial College Healthcare NHS Trust & David Barr, NIHR Clinical Lecturer, Infectious Diseases, University of Liverpool

A new approach to the economics of OPAT

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

Transforming NHS Pharmacy Aseptic Services in England

Andrew Davies, Director of Hospital Pharmacy, Pharmacy & Medicines Optimisation team – Improvement Directorate, NHS England

Q&A

All speakers

Value & Challenges of remote monitoring

John Williams, Consultant ID Physician, The James Cook University Hospital

OPAT vs COVID-19

Julie Statham, Principal Pharmacist for Infection, South Warwickshire NHS Foundation Trust & Rachel Kenion, Advanced Clinical Practitioner, South Warwickshire NHS Foundation Trust (SWFT)

Opportunities for OPAT practice during COVID-19

Sarah Logan, University College Hospital & Florence Taylor, OPAT Nurse, University College Hospital

Q&A

All speakers

COVID 19 & OPAT - The Australian Experience

Ben Rogers, Monash Health, Melbourne

Optimising dosing strategies in OPAT

Jason Roberts, University of Queensland

Q&A

All speakers

Opening from Chair, Appropriate Use of Quinolones in the OPAT Service, Close From Chair

David Jenkins, Consultant Medical Microbiologist, University of Leicester NHS TRUST & Vice President BSAC, Abid Hussain, Associate Medical Director & Infection Control Doctor at University Hospitals Birmingham NHS Foundation Trust

Developing a business case: The Nottingham story

Sue Snape, Consultant in Microbiology and Infectious Diseases, Nottingham University Hospitals NHS

The OPAT Good Practice Recommendations in Practice: the Good, the Bad and the Ugli

Ann Chapman, Consultant in Infectious Diseases and General Medicine, NHS Lanarkshire

A week in the life of the Wythenshawe OPAT service

Liz Wilson, OPAT Lead Nurse, Manchester University NHS Foundation Trust

Panel led discussion

All speakers

Opening from Chair: Delivering Value through Strategic Partnerships, The impact of a digital identification and management system on an OPAT service, Close From Chair: Delivering Value through Strategic Partnerships

Arthi Squires - Baxter Healthcare, Angela Innes - IV Nurse Practitioner, North Derbyshire Community OPAT service & Alison Johnson, Senior Clinical Pharmacist, Chesterfield Royal Hospital NHS Foundation Trust

Palliative OPAT

Aled Benbow, ST4 Infection, Nottingham City Hospital & Nicola Ball, Trust Grade doctor, OPAT department at Nottingham City Hospital

Bone and joint

Tariq Azamgarhi, Specialist Antimicrobial Pharmacist, Royal National Orthopaedic Hospital NHS Trust

Intraabdominal infections

Eoghan de Barra, Consultant in Infectious Diseases & General Internal Medicine, Beaumont Hospital, Dublin

Paediatric OPAT

Sanjay Patel, Paediatric Infectious Diseases and Immunology Consultant, Southampton Children’s Hospital

Panel discussion

All speakers

Closing remarks

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

Welcome and opening remarks

Mark Gilchrist, Consultant Pharmacist Infectious Diseases Imperial College Healthcare NHS Trust Co-Chair BSAC OPAT Initiative

Management of Aortic Graft Infections & OPAT

Nick Price, Director of Infection & Consultant Physician, Guy's & St Thomas' NHS Foundation Trust

Complex oral therapies in practice – the Hull experience

Monica Ivan, Consultant in Infectious Diseases, Hull University Teaching Hospitals NHS Trust

The UK Drug Stability Programme – developing a safer patient pathway for OPAT

Conor Jamieson, Pharmacy Team Leader – Antimicrobial Therapy, Sandwell and West Birmingham NHS Trust

POET and beyond. Oral antibiotic management of endocarditis

Henning Bundgaard, Professor of Cardiology, Faculty of Health and Medical Sciences, University of Copenhagen

Early experiences from OPAT in Switzerland

Serge De Valliere, Switzerland

Development of a fledgling OPAT service

Kailey Sassi-Jones & Owen Seddon, Wales

Equity of access to OPAT

Colin Sumpter, Public Health Registrar, NHS Lothian

Outcomes and challenges of implementing OVIVA in the management of bones and joint infections

Tariq Azamgarhi, Specialist Antimicrobial Pharmacist Royal National Orthopaedic Hospital

Securing regional support for OPAT: The Northern Ireland experience

Eileen Dorgan, Consultant Microbiologist, Antrim Hospital

Collective Intelligence to support OPAT expansion

Ann Cole, National Evolving Health Manager, Baxter Healthcare Ltd

Unusual cases treated with dalbavancin

Ali Khan, Specialist Registrar, Aberdeen Royal Infirmary

Talking about the AMR National Action Plan and the potential of OPAT

Philip Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals and University of Leeds

The enhanced role of pharmacists within the OPAT team

Peter McKee, Lead OPAT Pharmacist, Southern Health and Social Care Trust

Evolution of an OPAT service for low risk endocarditis patients. Combining the Infective Endocarditis MDT with new technology and outpatient services

James Hatherley, Clinical Fellow Cardiology, Aintree University Hospital

Developing a virtual OPAT clinic

Liz Wilson, Lead Nurse, OPAT Team, Wythenshawe Hospital

Moving OPAT from a “nice to have” to “must have” – how can we optimise use of UK NORS data?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases Imperial College Healthcare NHS Trust Co-Chair BSAC OPAT Initiative

Practical applications of the Good Practice Recommendations – how are we doing?

Ann Chapman, Consultant in Infectious Diseases and General Medicine, NHS Lanarkshire

OPAT Initiative, 2020 and beyond

Andrew Seaton, Infectious Diseases physician, Antibiotic stewardship lead NHS GGC, Chair of SAPG and co-chair of BSAC OPAT Initiative

Slido Questions and Answers

This document contains responses to questions raised at the conference through Slido – many of which could not be answered due to time constraints but for which we have sought responses from presenters post conference

Welcome and Opening Remarks

Mr Mark Gilchrist

My OPAT journey - a younger person's perspective, Question and Answer sessions

Mr Thomas Mallet

OPAT via telemedicine (Presentation via Skype)

Dr Paul Ingram

Defining the positive outcome - OPAT in palliative care

Dr Eoghan de Barra

Managing Staphylococcal Bacteraemias

Sanjita Brito-Mutunayagam

The challenge of orthopaedic infections in the post OVIVA era

Dr Bridget Atkins

Good Practice Recommendations - the key learning points

Dr Ann Chapman

Using OPAT to drive paediatric stewardship

Dr Sanjay Patel & Miss Emily Tanner

Beyond the OPAT MDT: hazards and opportunities

Dr Andrew Seaton

Speaking in favour

Dr Sue Snape

Speaking against

Dr Sarah Logan

Outpatient management of complex oral antibiotic regimens

Ms Julie Statham

ECG directed PICC line insertion

Mrs Elizabeth Wilson

Vascular health management in children

Miss Ruth Cantwell

A comparison of bolus versus infusion administration of ceftraiaxone in patients under OPAT

Miss Lucille Mclean

Evaluating the safety of antibiotic administration using elastomeric devises in children managed within a tertiary paediatric OPAT service

Mrs Jacqueline Gray

Setting up an in house elastomeric device service for OPAT

Dr Sue Snape

Role of OPAT in hemodialysis

Dr Carolyn Hemsley

Vascular graft infection and OPAT

Dr Fiona Andrewartha

Tubo-ovarian abscess and OPAT

Dr James Hatcher

Nurse led management of SSTIs

Ms Claire Vallance

Facilitated discussion addressing issues raised by delegates

Panel comprising: Mr Mark Gilchrist, Dr Andrew Seaton, Dr Sanjay Patel, Mrs Liz Wilson & Dr Ann Chapman

Case Study 1: UBI PUS, IBI EVAQUA & Case Study 2: Double Trouble

Dr Chris Lynch

Case Study 3: Bacteraemia, Haemodialysis and OPAT

Dr Hector Maxwell-Scott

Case Study 4: Bacteraemia, Haemodialysis and OPAT

Dr Anna Goodman

Role of extended dosing interval antimicrobials in OPAT

Dr Urania Rappo

Colour coded classification of OPAT patients as an alternative model of care

Ms Julie Statham

Developing a Risk Prediction Model for 30-Day Unplanned Hospitalisation in Patients Receiving Outpatient Parenteral Antimicrobial Therapy

Dr Chris Durojaiye

Identifying risk factors for non-completion of OPAT course to enable intervention before and during home treatment

Dr Ian Miskin

Using NORS data to optimise duration of antibiotic therapy in OPAT

Dr John Williams

A systematic review of Human Factors identified from Outpatient Parenteral Antimicrobial Therapy research using the SEIPS 2.0 model

Mrs Sara Jo Bugeja

Measuring practice and outcomes - Registry outputs and what they mean

Mr Mark Gilchrist

UK Drug Stability Testing Programme - outputs and future aspirations

Dr Conor Jamieson

OPAT 2019 and beyond

Mr Mark Gilchrist

Welcome and Opening Remarks

Mark Gilchrist

Download Slides

Fail better – the clinical story

Aisling Brown

Download Slides

Argument for early switching

Matt Scarborough

Download Slides

The role of IV therapy in Bone and joint infection

Andrew Seaton

Download Slides

An introduction to the development of RCN standards and rationale for Infusion therapy

Suman Shrestha

Download Slides

Infusion therapy: the patient perspective

Lynne Currie

Download Slides

Application of the infusion standards into practice

Sue Rowlands

Download Slides

Retrospective Audit of Outpatient Antimicrobial Parenteral Antimicrobial Therapy (OPAT) for Infective Endocarditis: 2014 – 2017

Karen Burns

Download Slides

The role of a Pharmacist Advanced Clinical Practitioner (ACP) within OPAT

Julie Wilkinson

Download Slides

Experience in the management of acute exacerbations of Bronchiectasis; a local perspective

Jo Spicer & Suzanne Carr

Download Slides

Maximising the opportunity of a self-administration OPAT pathway

Linda Mashonganyika

Download Slides

Malignant Otitis External: OPAT Experience at Nottingham

Fiona Andrewartha

Download Slides

OPAT the time for change in provider delivery

Andrew Davies

Download Slides

Chief Executive Officer view – what we need to hear

Duncan Haslow

Download Slides

Chief Finance Officer view – talking finances

Alison Rigby

Download Slides

Patient experience with vascular access

Linda Kelly

Download Slides

Infusion safety from a unique perspective

Paul Lee

Download Slides

Ambulatory OPAT in paediatrics: Same but different

Lucy Hinds

Download Slides

24 hour infusion – a new OPAT pathway for diabetic foot?

Naomi Fleming

Download Slides

Dalbavacin & OPAT – case series

Neil Ritchie

Download Slides

Clinical outcomes of midlines in community and hospital practice

Andrew Jackson

Download Slides

How the introduction of elastomeric devices has improved OPAT services at Wythenshawe Hospital

Liz Wilson

Download Slides

Expansion of P-OPAT service without a dedicated children’s community nursing team

Sally Bolsover

Download Slides

Developing a home OPAT service through cross organisational working

Alison Muir

Download Slides

Tuberculosis

Helena White

Download Slides

Non Cystic Fibrosis Bronchiectasis

Adam Hill

Download Slides

Patients as partners in care

Paul Whittle

Download Slides

Drug stability

Tim Hills

Download Slides

Update to the Good Practice Recommendations & Introduction of Competencies

Update to the Good Practice Recommendations & Introduction of Competencies

Download Slides

How can OPAT help deliver the NHS Five Year Forward View?

Philip Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals NHS Trust, Leeds

Download Slides

Endocarditis

Jonathan Sandoe, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds

Download Slides

Spinal Infections

Neil Ritchie, Clinical Lecturer in Infectious Diseases, Queen Elizabeth University Hospital, Glasgow

Download Slides

Paediatrics – a special population?

Sanjay Patel, Consultant Paediatrician, Southampton Children’s Hospital, Southampton

Download Slides

Clinical efficacy, cost-analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield OPAT service

Chris Durojaiye, Locum Consultant Physician, Royal Hallamshire Hospital, Sheffield

Download Slides

A re-audit evaluating the management of OPAT bronchiectasis patients against current BTS guidelines

Heather Boniface, F2-Paediatrics, Princess Royal Hospital, Telford

Download Slides

Success of an outpatient parenteral antimicrobial therapy (OPAT) programme in a large UK paediatric hospital

David Porter, Consultant in Paediatric Infectious Diseases, Alder Hey Hospital, Liverpool

Download Slides

Self-administration of intravenous antibiotics for OPAT

Emma Nickerson, Associate Specialist in Infectious Disease, Addenbrookes, Cambridge<

Download Slides

Learning outcome: Examining how to choose the right agent in the ambulatory care setting, including a review of licensed agents and drivers for prescribing – cost versus convenience versus stewardship versus stability

Susan Snape, Consultant Microbiologist, Nottingham University Hospitals, Nottingham
Sarah Williams, Deputy Lead Specialist Nurse, Nottingham University Hospitals, Nottingham
Tim Hills, OPAT Pharmacist, Nottingham University Hospitals, Nottingham
Elizabeth Hart, Infectious Disease and Acute Medicine Physician, Nottingham University Hospitals, Nottingham

Download Slides

Learning outcomes: Examining key factors in establishing admission avoidance services through safe, competency led services and appropriate patient selection

Sharon Bamber, OPAT Service Lead, Wirral University Teaching Hospital NHS, Merseyside
John Cunniffe, Consultant Microbiologist, Wirral University Teaching Hospital NHS, Merseyside

Download Slides

IVOST: principles and practice in OPAT

Andrew Seaton, Consultant Physician, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde

Download Slides

Oral Versus Intra-venous Antibiotic Treatment for Bone and Joint Infections

Matthew Scarborough, Infectious Diseases Consultant, Oxford University Hospitals NHS Trust, Oxford

Download Slides

Resurgence of older oral therapies in OPAT

Carolyn Hemsley, Consultant ID and Microbiology, Guys and St Thomas’s Hospital, London

Download Slides

Introduction: Tip location, CLABSI, Midlines and Passports

Andrew Jackson, IV Nurse Consultant, The Rotherham NHS Foundation Trust, Rotherham

Download Slides

Infection Prevention and Vascular Access

Martin Kiernan, Visiting Clinical Fellow, University of West London – GAMA Healthcare, London

Download Slides

Vessel Health and Preservation Framework

Tim Jackson, Consultant Anaesthetist & Intensivist at Calderdale & Huddersfield NHS Foundation Trust, Huddersfield

Download Slides

ECG PICC Tip Location

Gemma Oliver, Nurse Consultant Integrated IV Care at East Kent Hospitals University NHS Foundation Trust, Kent

Download Slides

Clinical efficacy of daily parenteral infusions of meropenem and ampicillin in the OPAT setting

James Pollard, Clinical Director, Hospital in the Home, Victoria, Australia

Download Slides

Instructive Endocarditis Case

Jonathan Sandoe, Associate Clinical Professor/Honorary Consultant Microbiologist, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds

Download Slides

A Case of Unintended Consequences – lessons to be learned

Beth White, Queen Elizabeth University Hospital, Glasgow

Download Slides

Staphylococcus aureus Bacteraemia & optimal OPAT management – doing the right thing isn’t always easy!

Eoghan de Barra, Consultant Infectious Diseases, Imperial College Healthcare Trust, London

Download Slides

Treating MDR Negatives in OPAT

Fiona Robb, Antimicrobial Pharmacist, NHS Greater Glasgow and Clyde, Glasgow

Download Slides

Paediatric OPAT: an Australasian approach

Penelope Bryant, Australasian Paediatric Antimicrobial Stewardship Group, Australia

Download Slides

Proving cost effectiveness in OPAT – what a commissioner needs to know

Sue Snape, Consultant Microbiologist, Nottingham University Hospitals, Nottingham

Download Slides

Community practice

Kate Owen, District Nurse Community IV Team Leader, Dudley Group of Hospitals NHS Trust, West Midlands

Download Slides

Acute practice

Gemma Oliver, Nurse Consultant IV Care, East Kent Hospital University NHS Trust, Kent

Download Slides

Establishing a regional the West Midland IV Forum

Kate Owen, District Nurse Community IV Team Leader, Dudley Group of Hospitals NHS Trust, West Midlands

Download Slides

Next steps and close

Download Slides

NIHR Summary of OPAT work

Jane Minton, Consultant in Infectious Diseases, Leeds Teaching Hospitals, Leeds

Download Slides

Revised EPIC3 guidelines impact on OPAT

Kate Owen, District Nurse Community IV Team Leader, The Dudley Group NHS Foundation Trust, Dudley

Download Slides

Drug stability – why open access publication of stability data is essential

Mark Santillo, Regional Quality Assurance Officer, Torbay & South Devon NHS Foundation Trust, Torquay

Download Slides

CLOSING REMARKS – Where next for the OPAT in the UK?

Mark Gilchrist, Consultant Pharmacist in Infectious Diseases, Imperial College Healthcare NHS Trust, London

Download Slides

The expanding OPAT landscape and integrated patient pathway

Dr Frances Sanderson

Download VideoDownload Slides

Paediatric OPAT provision – the challenges and opportunities

Dr Sanjay Patel

Download VideoDownload Slides

OPAT or No PAT: Emergency department and acute medical management of cellulitis in the UK

Dr Andrew Seaton

Download VideoDownload Slides

Towards developing OPAT competencies

Dr Ann Chapman

Download VideoDownload Slides

A new approach to the National Outcomes Registry

Mr Mark Gilchrist

Download VideoDownload Slides

Key challenges of IV to oral switch and use of oral agents

Dr Andrew Seaton

Download VideoDownload Slides

Facilitating early discharge through an IV to oral switch protocol

Dr Matthew Dryden

Download VideoDownload Slides

OVIVA Study

Dr Matthew Scarborough

Download VideoDownload Slides

FREE PAPER: The development of a unique model of OPAT

Gillian Runkee & Jayne Woodhead

Download VideoDownload Slides

FREE PAPER: Challenges of working with a private provider within an established OPAT service

Dr Elinor Moore

Download VideoDownload Slides

FREE PAPER: Managing bronchiectasis in the OPAT setting, a retrospective Audit

Dr John Eardley

Download VideoDownload Slides

FREE PAPER: The evolution of a National OPAT Program in Ireland 2013-2015

Dr Susie Clarke

Download VideoDownload Slides

FREE PAPER: Community IV antibiotics in Birmingham – collaborating to improve quality

Dr Neil Jenkins

Download VideoDownload Slides

FREE PAPER: The Blackpool OPAT model: An acute-primary care-CCG partnership developed community/home intravenous therapy service for residents of the Flyde Coast

Dr Achyut Guleri

Download VideoDownload Slides

Drug stability – an evidence review and development of a national methodology for stability testing of agents and devices

Mr Tim Hills

Download VideoDownload Slides

Drug stability testing in Hong Kong – lessons to share

Dr Joseph Kay-Yan TSANG

Download VideoDownload Slides

Fungal infections in the OPAT setting

Dr Eavan Muldoon

Download VideoDownload Slides

Intravenous drug user infections

Dr Dale Fisher

Download VideoDownload Slides

Intracerebral infections

Dr Eoghan de Barra

Download VideoDownload Slides

The BSAC Initiative 2015 to 2016 – the next important steps and closing remarks

Mr Mark Gilchrist

Download VideoDownload Slides

Welcome & Overview – The UK OPAT Initiative: Then, now & in the future and overview of the 2013 audit

Mark Gilchrist, Consultant Pharmacist, Imperial college Healthcare NHS Trust & Dr Andrew Seaton, Consultant Physician, Gartnavel General Hospital

Download VideoDownload Slides

OPAT & Paediatric OPAT standards and practical implications of the hospital and community

Dr Sanjay Patel, Consultant Paediatrician, Southampton University Hospital NHS Foundation Trust & Dr Ann Chapman, Consultant in Infectious Diseases, Royal Hallamshire Hospital, Sheffield

Download VideoDownload Slides

Recording OPAT treatment episodes and outcomes – Review of the UK Patient Management System and UK Outcomes Registry

Mark Gilchrist, Consultant Pharmacist, Imperial college Healthcare NHS Trust

Download VideoDownload Slides

Coding – The route to establishing an OPAT tariff

Debbie Cumming, Pharmacist, NHS Isle of Wight

Download VideoDownload Slides

Funding Acquisition and business case development

Dr Amandip Sahota, ST7 & Dr Susan Alleyne, Consultant Microbiologist, University Hospital of Leicester NHS Foundation Trust

Download VideoDownload Slides

Hall 5 – Key Considerations – Choice of antimicrobial agents and managing the IV to oral switch

Dr Andrew Seaton, Consultant Physician, Gartnavel General Hospital

Download VideoDownload Slides

Funding Acquisition and business case development – A Scottish perspective

Dr Claire Mackintosh, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh

Download VideoDownload Slides

Commissioning OPAT services – Balancing the Elements

Sharon Rourke, Senior Commissions Manager, Acute and Service Redesign, NHS Blackpool Clinical Commissioning Group

Download VideoDownload Slides

Hall 5 – Device choices for OPAT – Stability data and patient safety

Tim Hills, Antimicrobial Pharmacist, University Hospitals of Nottingham NHS Trust

Download VideoDownload Slides

Intravenous Antibiotics in homecare – The Bupa Experience

Stephen Cook, Director of Pharmacy, Bupa Home Healthcare

Download VideoDownload Slides

The District General Hospital Experience

Professor Sajjad Mirza, Consultant in Infectious Diseases, Royal Hallamshire Hospital, Sheffield

Download VideoDownload Slides

OPAT in the Teaching hospital / Tertiary centre

Dr Ann Chapman, Consultant in Infectious Diseases, Royal Hallamshire Hospital, Sheffield

Download VideoDownload Slides

OPAT community led service

Sue O’Hanlon, Lead Nurse IV Therapy, Bridgewater Community Healthcare NHS Trust

Download VideoDownload Slides

A Successful NHS provided service

Sister Kate Owen, District Nurse, Dudley Group NHS Foundation Trust

Download VideoDownload Slides

Successful fulfilment of an OPAT service through a private provider

Dr Susan Clarke, Clinical Lead for National OPAT Programme Ireland, St James’ Hospital, Dublin

Download VideoDownload Slides

Providing the best outcomes for patients – Closing remarks

Dr Frances Sanderson, Consultant in Infectious Diseases, Imperial College Healthcare NHS Trust

Download Video